TrialMedical oncology (Northwood, London, England)2014

Prognostic and predictive value of metabolic tumor volume on (18)F-FDG PET/CT in advanced biliary tract cancer treated with gemcitabine/oxaliplatin with or without erlotinib.

Moon Ki Choi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.